Free Trial
NYSE:QGEN

Qiagen Q1 2025 Earnings Report

Qiagen logo
$41.52 -0.80 (-1.88%)
Closing price 04/15/2025 03:59 PM Eastern
Extended Trading
$41.90 +0.38 (+0.91%)
As of 04:50 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Qiagen EPS Results

Actual EPS
N/A
Consensus EPS
$0.49
Beat/Miss
N/A
One Year Ago EPS
N/A

Qiagen Revenue Results

Actual Revenue
N/A
Expected Revenue
$465.66 million
Beat/Miss
N/A
YoY Revenue Growth
N/A

Qiagen Announcement Details

Quarter
Q1 2025
Time
After Market Closes
Conference Call Date
Thursday, May 8, 2025
Conference Call Time
9:00AM ET

Conference Call Resources

Remove Ads

Qiagen Earnings Headlines

Activist Fivespan built stake in Qiagen, holding talks, Bloomberg reports
What to do with your collapsing portfolio…
There might be only one way to save your retirement in this volatile time. After watching investors lose $6 trillion in market cap in a matter of DAYS... And after seeing businesses bleeding dry as trade tensions spiral out of control... What the acclaimed “Market Wizard” Larry Benedict — who beat the market by 103% during the 2008 crash — is about to reveal could not only save your retirement from Trump's tariffs…
See More Qiagen Headlines
Get Earnings Announcements in your inbox

Want to stay updated on the latest earnings announcements and upcoming reports for companies like Qiagen? Sign up for Earnings360's daily newsletter to receive timely earnings updates on Qiagen and other key companies, straight to your email.

About Qiagen

Qiagen (NYSE:QGEN) NV is a holding company, which engages in the provision of Sample to Insight solutions that enable customers to gain valuable molecular insights from samples containing the building blocks of life. The company sample technologies isolate and process DNA, RNA, and proteins from blood, tissue, and other materials. The firm assay technologies make these biomolecules visible and ready for analysis. Its bioinformatics software and knowledge bases interpret data to report relevant, actionable insights. The company was founded by Detlev H. Riesner and Metin Colpan on April 29, 1996, and is headquartered in Venlo, the Netherlands.

View Qiagen Profile

More Earnings Resources from MarketBeat